tk88 bet

Three new vaccines to be used in national vaccination programme

Vietnam will use three new vaccines in the national expanded vaccination programme (NEVP) this year, heard a workshop held by the Ministry of Health (MoH) on April 16.
Three new vaccines to be used in national vaccination programme ảnh 1Vietnam will use three new vaccines in the national expanded vaccination programme (Photo: VNA)

Hanoi (VNA) –༺ Vietnam will use threenew vaccines in the national expanded vaccination programme (NEVP) this year,heard a workshop held by the Ministry of Health (MoH) on April 16.


ComBe Five will replace Quinvaxem in the NEVP, according to Prof. Dang Duc Anh, Directorof the National Institute of Hygiene and Epidemiology (NIHE).

Quinvaxem (a combination vaccine for diphtheria,tetanus, pertussis and hepatitis B for children under one year old), which wasused in the NEVP for more than seven years, will be used nationwide until theend of May.

ComBe Five, a similar vaccine will be used in fourprovinces of Ha Nam, Binh Dinh, Kon Tum and Dong Thap, before being widelyutilised nationwide from June and July.

The India-made vaccine wasapproved by the MoH in May 2017, Anh said, adding that it is being used in morethan 43 countries and territories.

Vietnamstarted the use of five-in-one vaccine in June 2010, with about 41 million freeQuinvaxem doses provided for children under one year old.

At the workshop, the MoH also announced that theinactivated polio vaccine (IPV), with the support of “Gavi, the VaccineAlliance” and UNICEF, will be used in the NEVP for children of five months old,starting August 2018.

The IPV injections will be administered tochildren aged five months alongside the use of oral polio vaccine, which isprovided for children aged two, three and four months. 

This move is in conformity with the WorldHealth Organisation’s Polio Eradication and Endgame Strategic Plan2013–2018.  

▨ Vietnam controlled the spread of polio in 2000thanks to the deployment of polio vaccines in the NEVP.

In addition, the made-in Vietnamrubella vaccine has been used in the programme in 19 localities since April. Morethan 50,000 children of 18-24 months old have been immunised with the vaccine,with no reports of severe reactions.-VNA
VNA

See more

Assoc. Prof. Dr Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi, speaks online on Vietnam’s digital transformation strategy in medical education. (Photo: VNA)

ဣ Forum spotlights AI and digital innovation in healthcare

To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
A banner on the side of a car urges people to quit smoking for their own health and that of their loved ones (Photo: VNA)

🦹 Sharp tobacco tax hike urged to safeguard youths, community health

A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
On the morning of May 26, 2025, following bilateral talks at the Presidential Palace, President Luong Cuong (first, right) and French President Emmanuel Macron (first, left) witness the exchange of cooperation documents between leaders of ministries, agencies, and enterprises from both countries. In the photo: Ngo Chi Dung, General Director and Chairman of the Board of Viet Nam Vaccine Company (VNVC) (second, right), and Zainab Sadat Qayyum, President of Sanofi Southeast Asia – India, exchange the cooperation agreement on the transfer of Sanofi’s vaccine production technology to VNVC’s vaccine and biologicals plant. (Photo: VNVC)

꧃ Vietnam, France collaborate in vaccine production technology transfer

Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|{tk88 bet}|